← Leaderboards
Gavin R Graff
University Of Missouri-Columbia
$413,882
Attributed
$413,882
Total exposure
10
Grants
9
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $49.9K · FY2007–09$50K$37.5K$25K$12.5K$0
'07
'08
'09
Funding mix
By agency
NIH$413,882 · 10
By mechanism
P01$326,950 · 1
M01$86,932 · 9
Top collaborators
No co-investigators on record.
Most similar at University Of Missouri-Columbia
Same institution · by research overlap
- Dennis B Lubahn$3,325,524
- D Mark Estes$3,973,518
- Albert Y Sun$326,950
- K Rodabaugh$326,950
Others in their field
Top investigators on “Grant”
- David R. Weir · University Of Michigan At Ann Arbor$373,949,788
- David Heimbrook · Leidos Biomedical Research, Inc.$341,196,902
- Eric S Lander · Whitehead Institute For Biomedical Res$323,181,457
- Jeffrey P Krischer · University Of South Florida$258,583,867
- Lawrence Corey · Fred Hutchinson Cancer Center$253,286,867
- Barton F Haynes · Duke University$243,251,908
Research focus
GrantUnited States National Institutes Of HealthResourcesInstitutionResearch PersonnelFundingSourceComputer Retrieval Of Information On Scientific Projects DatabaseSafetyCystic FibrosisFatty Acid Glycerol EstersCystic Fibrosis PatientsPancreatic EnzymeProcess Of AbsorptionPancrelipasePlacebosMedical CenterNitrogenEffectivenessExocrine Pancreatic InsufficiencyClinical ResearchPurposePharmaceutical PreparationsChild
Grant awards (14)
PANCRELIPASE AND CYSTIC FIBROSIS$5,085
M01 · FY2009 · RR · contact PI
PANCRELIPASE DELAYED RELEASE CAPSULE IN PANCREATIC EXOCRINE INSUFFICIENCY & CF$30,022
M01 · FY2008 · RR · contact PI
EFFECTIVENESS OF PANCRELIPASE IN REDUCING STEATORRHEA IN CF CHILDREN & ADULTS$14,605
M01 · FY2008 · RR · contact PI
ENZYME TO IMPROVE CFA% CHILDREN WITH CYSTIC FIBROSIS (CF) AND PI$4,868
M01 · FY2008 · RR · contact PI
STUDY TO COMPARE SAFETY & EFFICACY OF ULTRASE MT20 IN CF$405
M01 · FY2008 · RR · contact PI
STUDY TO COMPARE SAFETY & EFFICACY OF ULTRASE MT20 IN CF$16,336
M01 · FY2007 · RR · contact PI
EEVALUATE SAFETY & EFFICACY OF EURAND PEP CYSTIC FIBROSIS$9,802
M01 · FY2007 · RR · contact PI
SAFETY & PHARMACOKINETICS OF 552-02 FOLLOWING FOURTEEN DAYS IN CYSTIC FIBROSIS$5,083
M01 · FY2007 · RR · contact PI
DENUFOSOL TETRASODIUM INHALATION SOLUTION IN PATIENTS W MILD CYSTIC FIBROSIS$726
M01 · FY2007 · RR · contact PI
Treatment of cystic fibrosis with soy derived isoflavones$65,390
P01 · FY2002 · ES
Treatment of cystic fibrosis with soy derived isoflavones$65,390
P01 · FY2002 · ES
Treatment of cystic fibrosis with soy derived isoflavones$65,390
P01 · FY2001 · ES
Treatment of cystic fibrosis with soy derived isoflavones$65,390
P01 · FY2001 · ES
Treatment of cystic fibrosis with soy derived isoflavones$65,390
P01 · FY2000 · ES